DK0519218T3 - Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-protein - Google Patents
Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-proteinInfo
- Publication number
- DK0519218T3 DK0519218T3 DK92108254T DK92108254T DK0519218T3 DK 0519218 T3 DK0519218 T3 DK 0519218T3 DK 92108254 T DK92108254 T DK 92108254T DK 92108254 T DK92108254 T DK 92108254T DK 0519218 T3 DK0519218 T3 DK 0519218T3
- Authority
- DK
- Denmark
- Prior art keywords
- kda
- coli
- antigen
- kda antigen
- host
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4116249A DE4116249A1 (de) | 1991-05-17 | 1991-05-17 | Hybrid-plasmid fuer m.-tuberculosis-antigen, e. coli als wirt und antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0519218T3 true DK0519218T3 (da) | 1999-08-02 |
Family
ID=6431926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92108254T DK0519218T3 (da) | 1991-05-17 | 1992-05-15 | Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-protein |
Country Status (8)
Country | Link |
---|---|
US (1) | US6110469A (fr) |
EP (1) | EP0519218B1 (fr) |
JP (1) | JPH05344894A (fr) |
AT (1) | ATE173506T1 (fr) |
DE (2) | DE4116249A1 (fr) |
DK (1) | DK0519218T3 (fr) |
ES (1) | ES2125873T3 (fr) |
NZ (1) | NZ242757A (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6752993B1 (en) | 1993-11-23 | 2004-06-22 | The Regents Of The University Of California | Abundant extracellular product vaccines and methods for their production and use |
US6592877B1 (en) | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6290969B1 (en) | 1995-09-01 | 2001-09-18 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6458366B1 (en) | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
WO1997041252A2 (fr) * | 1996-04-29 | 1997-11-06 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Adn, arn et proteine utiles pour dectecter une infection mycobacterienne |
US6013660A (en) * | 1996-10-02 | 2000-01-11 | The Regents Of The University Of California | Externally targeted prophylactic and chemotherapeutic method and agents |
US8143386B2 (en) | 1999-04-07 | 2012-03-27 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
CA2386841A1 (fr) | 1999-10-07 | 2001-04-12 | Corixa Corporation | Proteines hybrides de mycobacterium tuberculosis |
GB9924351D0 (en) | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
AU2001241738A1 (en) | 2000-02-25 | 2001-09-03 | Corixa Corporation | Compounds and methods for diagnosis and immunotherapy of tuberculosis |
ATE442866T1 (de) | 2000-06-20 | 2009-10-15 | Corixa Corp | Fusionsproteine aus mycobakterium tuberculosis |
US7026465B2 (en) | 2002-02-15 | 2006-04-11 | Corixa Corporation | Fusion proteins of Mycobacterium tuberculosis |
ITPR20040015A1 (it) * | 2004-02-24 | 2004-05-24 | Niro Soavi Spa | Procedimento e apparato per la rottura cellulare in una sospensione fluida in continuo. |
CN100457912C (zh) * | 2005-07-21 | 2009-02-04 | 复旦大学 | 重组Ag85B卡介苗 |
CN100350048C (zh) * | 2005-07-21 | 2007-11-21 | 复旦大学 | 一种重组卡介苗及其制备方法 |
WO2011007359A2 (fr) | 2009-07-16 | 2011-01-20 | Vaxil Biotherapeutics Ltd. | Vaccins anti-infection fondés sur plusieurs épitopes spécifiquews de l'antigène |
-
1991
- 1991-05-17 DE DE4116249A patent/DE4116249A1/de not_active Withdrawn
-
1992
- 1992-05-15 DK DK92108254T patent/DK0519218T3/da active
- 1992-05-15 ES ES92108254T patent/ES2125873T3/es not_active Expired - Lifetime
- 1992-05-15 NZ NZ242757A patent/NZ242757A/xx unknown
- 1992-05-15 EP EP92108254A patent/EP0519218B1/fr not_active Expired - Lifetime
- 1992-05-15 DE DE59209560T patent/DE59209560D1/de not_active Expired - Fee Related
- 1992-05-15 AT AT92108254T patent/ATE173506T1/de not_active IP Right Cessation
- 1992-05-18 JP JP4149895A patent/JPH05344894A/ja active Pending
-
1993
- 1993-08-05 US US08/102,505 patent/US6110469A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE173506T1 (de) | 1998-12-15 |
EP0519218A2 (fr) | 1992-12-23 |
DE59209560D1 (de) | 1998-12-24 |
JPH05344894A (ja) | 1993-12-27 |
EP0519218A3 (en) | 1993-10-20 |
DE4116249A1 (de) | 1992-11-19 |
ES2125873T3 (es) | 1999-03-16 |
NZ242757A (en) | 1993-09-27 |
US6110469A (en) | 2000-08-29 |
EP0519218B1 (fr) | 1998-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0519218T3 (da) | Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-protein | |
DK1047784T3 (da) | Neissera meningitidis-antigener | |
DK0776209T3 (da) | Polynukleinsyrer og proteiner fra et porcin reproduktiv og respiratorisk syndrom-virus og anvendelser deraf | |
ATE476508T1 (de) | Neisseriale antigene | |
DK0598816T3 (da) | Osp A-proteiner fra Borrelia Burgdorferi-undergrupper, hvilke proteiner koder for gener og vacciner | |
DE68929467D1 (de) | HIV-2 Varianten | |
DK0461079T3 (da) | Substituerede phthalider og heterocykliske phthalider | |
AU7607891A (en) | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles | |
PT721506E (pt) | Proteinas exportadas bacterianas e vacinas acelulares baseadas nestas | |
ATE183241T1 (de) | Impstoff gegen streptococcus suis-infektion | |
NO910131L (no) | Substituerte isoksazolidiner og isoksazoliner. | |
EP0379549A4 (en) | Endotoxin binding protein and uses thereof | |
DK160999C (da) | Plasmid p svh 1 og dets anvendelse | |
FI882444A (fi) | Substituerade vinylkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
DE69211161D1 (de) | Antibiotische 7-aminonaphthazarinderivate | |
ZA916106B (en) | Cloning and expression of a rhoptry-associated protein of p.falciparum | |
ATA211388A (de) | Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen | |
FR2712604B1 (fr) | Cassette de clonage et d'expression, vecteurs d'expression et bactéries transformées comprenant le promoteur Frup de R. Capsulatus; leurs applications. |